[Abstract] Viruses infect their host cells to produce progeny virus particles through the sequential steps of the viral life cycle, such as viral attachment, entry, penetration and post-entry events. This protocol describes time-of-addition and temperature-shift assays that are employed to explore which step(s) in the viral life cycle is blocked by an antiviral substance(s). (5) antiviral activity against attachment that occurs at both 37 °C and 4 °C and (6) antiviral activity against penetration (internalization and/or fusion) that occurs only at 37 °C. An interesting example is that
secreted phospholipase A2 obtained from bee venom inhibits penetration of human immunodeficiency virus (HIV) virion without inhibiting virion attachment to the cell surface (Fenard et al., 1999) .
In this article, we describe procedures of time-of-addition and temperature-shift assays for the mechanistic analyses of antiviral substances using a fluorescent antibody (FA) method, which have been reported elsewhere (Wahyuni et to each well (500 μl/well).
2.
Incubate the cells at 37 °C in a 5% CO2 incubator overnight.
Note: The cells become 80-90% confluent after overnight culture.

Day 2
1. Remove culture medium from each well.
2. Add 200 μl of culture medium containing serial dilutions of an antiviral substance (e.g., 1,000, 100, 10 and 1 ng/ml).
3. Incubate for 1 h to 24 h at 37 °C in a 5% CO2 incubator. 
Note: Virus is inoculated to cells in the absence of the antiviral substance.
7. Incubate for 1 h at 37 °C in a 5% CO2 incubator.
8. Remove the inoculum and rinse the cells three times with culture medium.
9. Add culture medium (500 μl/well) without the antiviral substance. 11. Put a small amount of Vectashield solution on a slide glass. Hold a coverslip with tweezers and touch the edge to a paper towel to remove excess PBS(-). Turn the coverslip upside-down and sandwich the coverslip and slide glass together, avoiding bubbles. After air-drying at room temperature in the dark, observe under a fluorescence microscope. 
Note: Infectivity of vesicular stomatitis New Jersey virus (VSNJV), Sindbis virus (SINV) and encephalomyocarditis virus (EMCV
